Search
Now showing items 1-10 of 33
TP53 Mutation and Survival in Chronic Lymphocytic Leukemia
Wissenschaftlicher Artikel
(Universität Ulm, 2010)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Wissenschaftlicher Artikel
(Universität Ulm, 2018)
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Wissenschaftlicher Artikel
(Universität Ulm, 2014)
Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia
Wissenschaftlicher Artikel
(Universität Ulm, 2013)
Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials
Wissenschaftlicher Artikel
(Universität Ulm, 2014)
PTK2 expression and immunochemotherapy outcome in chronic lymphocytic leukemia
Wissenschaftlicher Artikel
(Universität Ulm, 2014)
NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab: results from the CLL2H trial of the GCLLSG
Wissenschaftlicher Artikel
(Universität Ulm, 2013)
Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
Wissenschaftlicher Artikel
(Universität Ulm, 2012)
Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
Wissenschaftlicher Artikel
(Universität Ulm, 2011)
Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial
Wissenschaftlicher Artikel
(Universität Ulm, 2016)